01 1Intas Pharmaceuticals
01 1DOXORUBICIN HYDROCHLORIDE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-03-22
Pay. Date : 2020-01-20
DMF Number : 34545
Submission : 2020-01-27
Status : Active
Type : II
20
Intas Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DOXORUBICIN HYDROCHLORIDE USP, with a corresponding US DMF Number 34545.
Remarkably, this DMF maintains an Active status since its submission on January 27, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 22, 2020, and payment made on January 20, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
